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Abstract 
Introduction: A large number of congenital hypothyroidism (CH) cases in Iran are transient. This study was designed to investigate the 
aetiology of permanent CH (PCH) by thyroid scintigraphy (TS) and its relationship with the first diagnostic thyrotropin (TSH). 
Material and methods: During 12 years (2005–2017) of CH screening in southwest Iran, all infants referred with the diagnosis of CH were 
followed until their third birthday, when they were re-evaluated for serum T4, TSH after discontinuing the treatment for 3–4 weeks. If 
the last test indicated a PCH state (TSH >10 mU/L with any levels of T4), TS was performed, and, based on the results, the patients were 
categorised as agenesis, dysgenesis (sublingual, thyroglossal cyst), and normal/diffuse goitre (indicating dyshormonogenesis). 
Results: After excluding all transient CH subjects, 224 permanent CH cases were enrolled (52.7% female). Seasonal distributions were as 
follows: spring: 25.7%, summer: 27.9%, autumn: 20.3%, and winter: 26.1%. No significant differences were found between females and 
males and the different modes of delivery (55.4% were delivered by caesarean section) regarding T4, TSH (p > 0.05). Of a total of 213 
performed scans, 20.7% had agenesis, 36.2% had dysgenesis, and 43.2% were normal or goitrous. Those with agenesis/dysgenetic thyroid 
had a lower T4 and a higher TSH than those with normal scans. However, the differences were not significant. Compared to those who 
had TSH < 40 mU/L, patients with TSH ≥ 40mU/L had 46% (95% CI; 1.06–2.02) more risk of agenesis or dysgenesis in TS. 
Conclusions: More than 40% of PCH are caused by dyshormonogenesis in Iran. Having a TSH ≥ 40 mU/L after the first week of life sig-
nificantly raises the probability of thyroid agenesis/dysgenesis as the cause. (Endokrynol Pol 2019; 70 (1): 43–48)
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Streszczenie
Wstęp. W populacji irańskiej wrodzona niedoczynność tarczycy (CH) ma w wielu przypadkach charakter przemijający. Przedstawione 
badanie przeprowadzono w celu oceny etiologii trwałej CH (PCH) na podstawie scyntygrafii tarczycy oraz zależności między wynikami 
tego badania a stężeniem tyreotropiny (TSH) w pierwszym badaniu diagnostycznym. 
Materiał i metody. W okresie 12 lat (2005–2017), w którym prowadzono przesiewowe badania pod kątem CH w południowo-wschodnim 
Iranie, wszystkie dzieci skierowane do ośrodka autorów obserwowano do ukończenia 3. roku życia, kiedy przeprowadzano ponowną 
ocenę stężenia w surowicy T4 i TSH po zaprzestaniu leczenia na 3–4 tygodnie. Jeśli ostatnie badanie sugerowało PCH (TSH >10 mj./l, 
niezależnie od stężenia T4), wykonywano scyntygrafię tarczycy i w zależności od wyniku przydzielano chorych do jednej z następujących 
kategorii: agenezja, dysgenezja (tarczyca podjęzykowa, torbiel przewodu tarczowo-językowego), tarczyca prawidłowa/wole guzkowe 
(wskazujące na dyshormonogenzę). 
Wyniki. Po wykluczeniu z badania wszystkich dzieci z przemijającą CH do analizy włączono 224 przypadki trwałej CH (52,7% badanych 
było płci żeńskiej). Rozkład w zależności od pory roku był następujący: wiosna — 25,7%, lato — 27,9%, jesień — 20,3%, zima — 26,1%. 
Nie stwierdzono istotnych różnic w stężeniach T4 i TSH między dziewczętami i chłopcami ani różnymi typami porodu (55,4% dzieci 
urodziło się przez cesarskie cięcie) (p > 0,05). Spośród 213 dzieci, u których wykonanych scyntygrafię, u 20,7% stwierdzono agenezję, 
u 36,2% — dysgenezję, a u 43,2% — prawidłową tarczycę lub wole. U dzieci z agenezją/dysgenezją tarczycy stężenie T4 było niższe, 
a stężenie TSH wyższe niż u dzieci z prawidłowym obrazem tarczycy w scyntygrafii. Jednak różnice nie były istotne statystycznie. Ryzy-
ko stwierdzenia agenezji lub dysgenezji tarczycy w badaniu scyntygraficznym było o 46% wyższe (95% CI; 1,06–2,02) u osób, u których 
stężenie TSH wynosiło ≥ 40 mj./l w porównaniu z osobami, u których stężenie TSH wynosiło < 40 mj./l. 
Wnioski: Ponad 40% przypadków PCH w Iranie jest spowodowanych dyshormonogenezą. Stężenie TSH ≥ 40 mj./l po pierwszym tygo-
dniu życia istotnie zwiększa prawdopodobieństwo, że przyczyną niedoczynności tarczycy jest agenezja lub dysgenezja tego narządu. 
(Endokrynol Pol 2019; 70 (1): 43–48)
Słowa kluczowe: wrodzona niedoczynność tarczycy; badania przesiewowe; dysgenezja tarczycy; scyntygrafia tarczycy
Introduction 
Congenital hypothyroidism (CH) was reported to be 
more prevalent in the Asian population [1]. A large 
number of cases were reported as transient [2, 3], pos-
sibly caused by maternal and/or environmental factors 
[4–6]. In these situations, the clinician must be careful 
to avoid unnecessary treatment while not losing any 
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(AJUMS). There were no requirements for free and in-
formed consent because there have been no changes in 
medical procedures such as additional blood sampling 
or imaging, and the participants were not identified. 
Moreover, no additional charges were imposed on 
the subjects. The author was the only focal point for 
the referral and follow-up of the screening program 
authorised by AJUMS. 
They were followed up until their third birthday, 
and then re-evaluation was performed for thyroid 
function tests (T4, TSH) following a 3–4-week treat-
ment discontinuation. At this stage, those who had 
normal TSH were labelled as transient CH and were 
followed with scheduled rechecks for two more years 
to make sure that there was no recurrence. Those who 
had TSH rising (> 10 mU/L in the first or subsequent 
tests after levothyroxine discontinuation) were con-
sidered as permanent CH and were investigated by 
thyroid scintigraphy by technetium pertechnetate 
99m (Tc-99mTS). Based on the TS results, they were 
categorised as agenesis (absence of thyroid uptake), 
dysgenesis (hypoplastic, hemiagenesis, sublingual, 
submandibular, ectopic, or thyroglossal cyst), and dys-
hormonogenesis (normal location of thyroid with nor-
mal or increased size and technetium uptake) (Fig. 1). 
In four of the subjects, thyroid ultrasonography was 
performed instead, due to concerns about radiation or 
poor cooperation. A normal size of thyroid categorised 
them as dyshormonogenesis. 
Data regarding sex, month and season of birth, 
mode of delivery (caesarean section, or vaginal deliv-
ery), birth order, first diagnostic serum T4, TSH level, 
third year re-evaluation TSH values, and the TS results 
were collected and analysed to find their relationships 
with the outcome. 
CH subjects secondary to hypophyseal disorder 
were excluded from the study. 
Statistical analysis
Statistical analysis of the data was performed using 
Statistical Package for the Social Sciences 16.0 (SPSS, 
Inc., Chicago, IL, USA, Microsoft) software. Results were 
expressed as mean ± standard deviation. Student’s 
t-test was used for the comparison of the means for 
numeric variables and the chi-square test for compar-
ing the means for non-numeric variables. Relative risk 
index was used for risk assessment. P values < 0.05 
were considered as significant.
Results 
During the study, 224 [118 female (52.7%); female to 
male = 1.11) subjects with confirmed permanent pri-
mary CH were enrolled. Seasonal distributions were as 
permanent CH subject [7]. According to most CH 
screening plans [8], a heal prick whole blood thyrotro-
pin (TSH) measurement and, if needed, a confirmatory 
serum test for thyroxine (T4) and TSH are tests required 
for the diagnosis and the appropriate management of 
all neonates [1]. In screening programs for common 
congenital disorders, some additional investigations 
are included with different aims. Prevention of having 
another sick baby by genetic studies, similar to what is 
being performed for phenylketonuria, has no place in 
the CH program. However, determining the underly-
ing aetiology and outcome by thyroid scintigraphy 
(TS) is of great importance [9, 10]. Some researchers 
have investigated the CH aetiology by TS at the time 
of diagnosis [11, 12]. However, performing TS does 
not change the treatment plan during the early years 
of management. Nevertheless, if it reveals a dysplastic 
thyroid gland (absence or ectopic, usually a small sub-
lingual gland), parents can be told that the infant will 
need lifelong therapy. 
It is commonly recommended that all patients be 
re-evaluated [13] after their third birthday [14] (when 
the critical period of brain development has passed), 
with a short period of treatment discontinuation to 
confirm if they are permanent or transient [5]. This is the 
best opportunity to exclude transient subjects and leave 
other investigations only for those with permanent CH. 
Based on the high prevalence of CH in Iran where 
almost half of the cases have been transient [15, 16] 
and the popularity of consanguinity [17] is reported 
to have increased the CH prevalence mostly due to 
dyshormonogenesis rather than dysgenesis [18], this 
study was designed to determine the different aetiolo-
gies of permanent CH in this country, using thyroid 
scintigraphy (TS), and to investigate the relationship 
between the first diagnostic serum TSH and TS results. 
This study is the biggest study regarding the case 
number and the study course, which helped determine 
the aetiology of permanent CH after excluding all tran-
sient subjects in an Asian country with a high rate of 
consanguinity. It shows the role of genetics as the cause 
of dyshormonogenesis as well as more severe thyroid 
dysfunction in patients with agenesis/dysgenesis com-
pared to dyshormonogenesis.
Material and methods 
The screening program for CH started in Iran in 2005. 
During 12 years of study (until 2017), all subjects with the 
diagnosis of CH (diagnosed by the author since early life 
or referred to the author at any age as a focal point and 
paediatric endocrine consultant) were studied.
The study was approved by the Ethics Committee 
of Ahvaz Jundishapur University of Medical Sciences 
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follows: spring: 25.7%, summer: 27.9%, autumn: 20.3%, 
and winter: 26.1%. 
With regard to the mode of delivery, 44.6% were 
born via normal delivery and 55.4% by caesarean sec-
tion (C/S).
Regarding the birth order, 46.1% were the first, 
32% the second, 11.7% the third, 5.8% the forth, 
3.9% the fifth, and 0.5% the sixth child of their fami-
lies. Of a total of 213 performed scans, 44 subjects 
(20.7%; F/M = 24/20 = 1.2/1) had agenesis, 77 (36.2%; 
F/M = 51/26 = 1.96/1) had dysgenesis, and 92 (43.2%; 
F/M = 38/54 = 0.7/1) were normal or goitrous (indicat-
ing dyshormonogenesis) (Tab. I).
There were no significant differences between 
females and males regarding T4 as well as TSH at the 
time of diagnosis (p > 0.05). Infants born via C/S had 
more serum values for both T4 and TSH (6.49 ± 10.7 
vs. 4.99 ± 3.7 and 109.38 ± 165.7 vs. 85.30 ± 83.3, re-
spectively) but these differences were not significant 
(p > 0.05).
Compared to those who had normal scans, pa-
tients with thyroid agenesis/dysgenesis had lower 
T4 (4.8 ± 3.5 vs. 7.65 ± 12.8 mg/dL) and higher TSH 
(125.8 ± 169.3 vs. 103.5 ± 118.5 mU/L) but none was 
significant (p > 0.05). 
Compared to those who had TSH < 40 mU/L, 
patients with TSH ≥ 40 mU/L had a 46% (RR = 1.46; 
CI 95%: 1.06–2.02) higher risk of having abnormal TS 
results (Fig. 2). 
Discussion 
As was expected, higher neonatal serum TSH values 
were found in those with athyreosis/dysgenesis com-
Figure 1. A. 3.5-year-old girl with TSH = 104.9 mU/L in neonatal confirmatory test, and 40.7 mU/L in re-evaluation. Scan showed 
no uptake at the bed of thyroid gland and no ectopic absorption at neck and oral cavity indicating congenital absence of thyroid. 
B. A 4-year-old girl with a TSH = 40 mU/L in neonatal confirmatory test and TSH = 289 mU/L in re-evaluation. Scan showed no uptake 
at the bed of thyroid gland but there was ectopic radiotracer absorption at oral cavity at the base of the tongue indicating lingual thyroid. 
C. A 3.5-year-old girl with TSH = 22.5 mU/L in neonatal confirmatory test and TSH = 23.7 mU/L at the three-year re-evaluation. 
Scan revealed ectopic radiotracer absorption at midline of upper neck as well as in oral cavity at the base of the tongue (arrows), but 
thyroid lobes were not visualised. Double thyroid ectopia, lingual and at the course of thyro-glossal duct was suggested. D. A 6-year, 
10-month-old boy with confirmatory TSH > 100 mU/L and treatment since 30th day of life. After discontinuation of levothyroxine TSH 
raised to > 100 mU/L and goitre was visible clinically. Scan revealed enlarged thyroid with increase and rather homogenous uptake of 
radiotracer of both lobes indicating dyshormonogenesis (parental consent obtained for photography)
Rycina 1. A. Dziewczynka w wieku 3,5 roku, u której wynik badania stężenia TSH w okresie noworodkowym wynosił 104,9 mj./l, 
a wynik ponownego badania — 40,7 mj./l. W badaniu scyntygraficznym stwierdzono brak wychwytu w łoży tarczycy oraz brak ektopowej 
absorpcji w obrębie szyi i jamy ustnej, co świadczy o wrodzonym braku tarczycy. B. Dziewczynka w wieku 4 lat, u której wynik badania 
stężenia TSH w okresie noworodkowym wynosił 40 mj./l, a wynik powtórnego badania — 289 mj./l. W badaniu scyntygraficznym 
stwierdzono brak wychwytu w łoży tarczycy, lecz zaobserwowano ektopową absorpcję radioznacznika w jamie ustnej u podstawy 
języka, co wskazuje na obecność tarczycy językowej. C. Dziewczynka w wieku 3,5 roku, u której wynik badania stężenia TSH w okresie 
noworodkowym wynosił 22,5 mj./l, a wynik ponownego badania — 23,7 mj./l. W badaniu scyntygraficznym stwierdzono ektopową 
absorpcję radioznacznika w linii pośrodkowej w górnej części szyi oraz w jamie ustnej u nasady języka (strzałki), jednak płaty tarczycy 
nie zostały uwidocznione. Sugerowano podwójną ektopię tarczycy: tarczyca językowa i zlokalizowana wzdłuż przebiegu przewodu 
tarczowo-językowego. D. Chłopiec w wieku 6 lat i 10 miesięcy, u którego wynik diagnostycznego oznaczenia TSH wynosił > 100 mj./l 
i który był leczony od 30. dnia życia. Po zaprzestaniu podawania lewotyroksyny stężenie TSH wzrosło do > 100 mj./l, a wole było 
wyraźnie widoczne. W badaniu scyntygraficznym uwidoczniono powiększoną tarczycę ze zwiększonym i raczej jednorodnym wychwytem 
radioznacznika w obu płatach, co wskazuje na dyshormonogenezę (rodzice wyrazili zgodę na publikację zdjęcia)
A
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pared to subjects with dyshormonogenesis, indicating 
greater severity of the disorder and requiring serious 
follow-up in these subjects.
Iranpour et al. [11], in a study on 116 neonates with 
the diagnosis of CH requiring replacement levothy-
roxine treatment, performed early pre-treatment TS to 
classify them based on aetiology. They found that only 
28.5% of them were athyreotic and 6% had dysgenesis; 
all the rest (65%) had a normal scan result. This study 
showed a significantly higher TSH value in those with 
agenesis. Similarly to Iranpour’s study [11], the author 
also found higher TSH levels in athyreotic subjects, but 
the distribution of our patients in the TS classification 
was different (Table II). The smaller percentage of nor-
mal scans (≈ 40% dyshormonogenesis) in our study was 
due to the exclusion of transient cases before scanning. 
El-desouki et al. [12] in Saudi Arabia designed 
a study similar to the previously-mentioned study and 
performed scanning for 147 CH patients . Their results 
were similar to our study (Tab. II).
Albert et al. reviewed the incidence of CH in New 
Zealand in a screening program covering 18 years 
[18]. Near two thirds of their cases were found to have 
dyshormonogenesis. An interesting point of their study 
was the increasing incidence of CH in New Zealand, 
mostly related to dyshormonogenesis. They explained 
this rise by the increase in Asian population immigra-
tion to New Zealand during that period.
Table I. Classification of scintiscan results in 180 patients with permanent congenital hypothyroidism (CH) based on their 
first diagnostic TSH values
Tabela I. Klasyfikacja wyników scyntygrafii u 180 chorych z trwałą wrodzoną niedoczynnością tarczycy (CH) w zależności 
od wartości pierwszego diagnostycznego badania stężenia TSH
Final Scintiscan result
TSH value Agenesis Dysgenesis All abnormal Normal Total 
≥ 40* 40 (30.1)** 51 (38.3) 91 (68.4) 42 (31.6) 133 (100)
< 40 1 (2.12) 21 (44.68) 22 (46.8) 25 (53.2) 47 (100)
20–39.9 0 (0) 8 (36.4) 8 (36.4) 14 (63.6) 22 (100)
< 20 1 (4) 13 (52) 14 (56) 11 (44) 25 (100)
Total 41 (22.8) 72 (40) 113 (66.8) 67 (37.2) 180 (100)
*mU/L; **Number in parenthesis shows the percentage in each TSH group
Table II. The results and comparison of five studies investigated underlying cause of congenital hypothyroidism (CH) based 
on thyroid scintigraphy
Tabela II. Porównanie wyników uzyskanych w pięciu badaniach oceniających przyczyny wrodzonej niedoczynności tarczycy 
(CH) na podstawie badania scyntygraficznego
Study Agenesis Dysgenesis Normal No.***
Aminzadeh 2018 20.7* (1.2/1)** 36.2 (1.96/1) 43.2 (0.7/1) 213
Albert et al [18] 2012 67 (5/1) 33 (0.9/1) 284
Iranpour [11] 2006 28.4 (0.8/1) 6 (1.3/1) 65.6 (1.5/1) 116
Eugene et al [19] 2005 16 (1.4/1) 68 (3.25/1) 15 (0.69/1) 148
El-desouki et al. [12] 1995 22 (1.67/1) 42 (2.26/1) 36 (1.2/1) 147
*Numbers show the percentage of total studied subjects. **Numbers in the parenthesis show female–to–male ratio. ***Total number of cases in each study
Figure 2. Distribution of abnormal (agenesis/dysgenesis) and 
normal results of thyroid scintiscan performed after the 3rd 
birthday re-evaluation, in 180 patients with permanent congenital 
hypothyroidism, based on their first neonatal diagnostic TSH 
values
Rycina 2. Dystrybucja nieprawidłowych (agenezja/dysgenezja) 
i prawidłowych wyników powtórnych badań scyntygraficznych 
tarczycy wykonanych po ukończeniu 3 lat życia u 180 chorych 
z  trwałą wrodzoną niedoczynnością tarczycy w zależności 
od stężenia TSH oznaczonego w  czasie pierwszego badania 
diagnostycznego wykonanego w okresie noworodkowym
Neonatal diagnostic TSH value [mU/L]
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Another study performed by Eugene et al. [19] on 
148 permanent CH subjects in Quebec, Canada report-
ed only 15% of normal scan results, matching with a pat-
tern of CH aetiology in a typical western country, which 
was mostly caused by sporadic dysgenesis rather than 
familial genetically-based dyshormonogenesis. Table 2 
shows a brief comparison of the five mentioned stud-
ies and their findings conducted in different countries.
Regarding the mode of delivery, 44.6% were born 
via vaginal delivery (VD) and 55.4% by caesarean sec-
tion (C/S). This finding is close to what we see in the 
general population in Iran. This high prevalence of C/S 
deliveries is related to women’s preferences rather than 
obstetric issues. 
Turan’s study in Turkey [20] showed an insigni-
ficantly higher TSH value in neonates born via VD 
compared to those via C/S, but similar to the study of 
McElduff et al. [21]; our subjects with a history of C/S 
had a slightly higher mean for T4 and TSH, although 
these differences were not significant. After excluding 
personal interests, those with caesarean deliveries are 
likely to have valuable differences in this regard. 
Regarding the birth order, 90% of the cases were 
born as the first, the second, or the third child of their 
families. This only showed a higher attitude of parents 
to have only one or two children at most. However, 
some studies [22] have reported a change in CH preva-
lence in different birth orders. In concordance with the 
study of Rosenthal [23], birth order in our CH subjects 
was not significantly different from that of the general 
population.
Seasonal distributions were found to be as follows: 
spring: 25.7%, summer: 27.9%, autumn: 20.3%, and 
winter: 26.1%. The author’s previous study (6) in this 
region had disclosed a different pattern: spring: 19%, 
summer: 13.4%, autumn: 32.4%, and winter: 35.2%. 
In an opposite direction, Hashemipour et al. [24] re-
ported a higher prevalence of CH in the warm season 
of the year. The two studies above had enrolled both 
transient and permanent CH patients, but the present 
research surveyed only permanent CH subjects. This 
may explain the aforementioned difference in seasonal 
patterns. Higher incidence of CH in cold or warm sea-
sons of the year were related mostly to the aetiology 
of transient CH, and the regular incidence of CH over 
the year in this study matches with the aetiologies of 
permanent CH, not changing over the year. 
Study limitations 
In this study, all negative (no uptake) TS indexes were 
considered as agenesis, but there are some other pos-
sibilities. Absence of uptake can also be seen by TSHb 
gene mutations, TSH receptor inactivating mutations, 
iodide trapping defects, and maternal transfer of 
thyrotropin receptor blocking antibodies (TRB-Ab). 
Thyroid ultrasonography and other investigations 
such as the measurement of serum thyroglobulin or 
TRB-Ab will help differentiate these aetiologies from 
thyroid agenesis.
Actually, a combination of thyroid scan and ultraso-
nography provides maximal information to the clinician 
about thyroid function and its anatomic status. Then 
the real rate of dyshormonogenesis could be a little bit 
higher than what was reported in this study.
Conclusions 
More than 43% of permanent CH subjects in Iran are 
caused by dyshormonogenesis. Compared to those 
with TSH < 40 mU/L, higher values have greater risk 
of having abnormal thyroid structure. 
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